{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:41:59Z","timestamp":1768351319903,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,10]]},"DOI":"10.7759\/cureus.71229","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T22:59:39Z","timestamp":1728601179000},"source":"Crossref","is-referenced-by-count":2,"title":["Infections Combined With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Case Report and Systematic Review of the Literature"],"prefix":"10.7759","author":[{"given":"Huiyao","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moushan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier R","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo A, et al.. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021, 20:762-72. 10.1016\/S1474-4422(21)00218-0","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1137998","article-title":"Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease","volume":"14","author":"Corbali O","year":"2023","unstructured":"Corbali O, Chitnis T. Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease. Front Neurol. 2023, 14:1137998. 10.3389\/fneur.2023.1137998","journal-title":"Front Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl M","year":"2019","unstructured":"Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019, 15:89-102. 10.1038\/s41582-018-0112-x","journal-title":"Nat Rev Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.0394-22","article-title":"Anti-myelin oligodendrocyte glycoprotein antibody-positive myelitis after coronavirus disease 2019","volume":"62","author":"Uchino K","year":"2023","unstructured":"Uchino K, Soga K, Shinohara K, Imai T, Motohashi I, Okuma H, Yamano Y. Anti-myelin oligodendrocyte glycoprotein antibody-positive myelitis after coronavirus disease 2019. Intern Med. 2023, 62:1531-5. 10.2169\/internalmedicine.0394-22","journal-title":"Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1604404","article-title":"MOG spectrum disorders and role of MOG-antibodies in clinical practice","volume":"49","author":"Hennes EM","year":"2018","unstructured":"Hennes EM, Baumann M, Lechner C, Rost\u00e1sy K. MOG spectrum disorders and role of MOG-antibodies in clinical practice. Neuropediatrics. 2018, 49:3-11. 10.1055\/s-0037-1604404","journal-title":"Neuropediatrics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell B","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, et al.. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023, 22:268-82. 10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11737-8","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges","volume":"270","author":"Al-Ani A","year":"2023","unstructured":"Al-Ani A, Chen JJ, Costello F. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges. J Neurol. 2023, 270:4132-50. 10.1007\/s00415-023-11737-8","journal-title":"J Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.0912","article-title":"Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing","volume":"78","author":"Sechi E","year":"2021","unstructured":"Sechi E, Buciuc M, Pittock SJ, et al.. Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing. JAMA Neurol. 2021, 78:1-6. 10.1001\/jamaneurol.2021.0912","journal-title":"JAMA Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab105","article-title":"Features of MOG required for recognition by patients with MOG antibody-associated disorders","volume":"144","author":"Macrini C","year":"2021","unstructured":"Macrini C, Gerhards R, Winklmeier S, et al.. Features of MOG required for recognition by patients with MOG antibody-associated disorders. Brain. 2021, 144:2375-89. 10.1093\/brain\/awab105","journal-title":"Brain"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.850743","article-title":"Clinical features and imaging findings of myelin oligodendrocyte glycoprotein-IgG-associated disorder (MOGAD)","volume":"14","author":"Li Y","year":"2022","unstructured":"Li Y, Liu X, Wang J, Pan C, Tang Z. Clinical features and imaging findings of myelin oligodendrocyte glycoprotein-IgG-associated disorder (MOGAD). Front Aging Neurosci. 2022, 14:850743. 10.3389\/fnagi.2022.850743","journal-title":"Front Aging Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management","volume":"13","author":"Sechi E","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, et al.. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol. 2022, 13:885218. 10.3389\/fneur.2022.885218","journal-title":"Front Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-00645-3","article-title":"Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation","volume":"7","author":"Vanheusden M","year":"2017","unstructured":"Vanheusden M, Broux B, Welten SP, et al.. Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation. Sci Rep. 2017, 7:663. 10.1038\/s41598-017-00645-3","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13239","article-title":"Pathogen infection and autoimmune disease","volume":"195","author":"Christen U","year":"2019","unstructured":"Christen U. Pathogen infection and autoimmune disease. Clin Exp Immunol. 2019, 195:10-4. 10.1111\/cei.13239","journal-title":"Clin Exp Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109183","article-title":"Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection","volume":"112","author":"Vahabi M","year":"2022","unstructured":"Vahabi M, Ghazanfari T, Sepehrnia S. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection. Int Immunopharmacol. 2022, 112:109183. 10.1016\/j.intimp.2022.109183","journal-title":"Int Immunopharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2022.2124794","article-title":"Myelin oligodendrocyte glycoprotein (MOG) antibody-associated meningoencephalitis due to Mycoplasma pneumoniae infection","volume":"45","author":"Zeng XD","year":"2023","unstructured":"Zeng XD, Chen H, Hu WG. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated meningoencephalitis due to Mycoplasma pneumoniae infection. Neurol Res. 2023, 45:124-6. 10.1080\/01616412.2022.2124794","journal-title":"Neurol Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/sjmms.sjmms_791_20","article-title":"Transient myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis following influenza a infection: a rare case","volume":"9","author":"Nasa P","year":"2021","unstructured":"Nasa P, Mortada M, Singh A, Malhotra V, Syed H. Transient myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis following influenza a infection: a rare case. Saudi J Med Med Sci. 2021, 9:271-5. 10.4103\/sjmms.sjmms_791_20","journal-title":"Saudi J Med Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_1054_20","article-title":"Anti-myelin oligodendrocyte glycoprotein antibody positive acute disseminated encephalomyelitis post-varicella zoster virus infection","volume":"24","author":"Yadav A","year":"2021","unstructured":"Yadav A, Sharma R, Ganiger MP, Sharma G. Anti-myelin oligodendrocyte glycoprotein antibody positive acute disseminated encephalomyelitis post-varicella zoster virus infection. Ann Indian Acad Neurol. 2021, 24:797-9. 10.4103\/aian.AIAN_1054_20","journal-title":"Ann Indian Acad Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.17-0938","article-title":"Case report: acute transverse myelitis after zika virus infection","volume":"99","author":"Neri VC","year":"2018","unstructured":"Neri VC, Xavier MF, Barros PO, Melo Bento C, Marignier R, Papais Alvarenga R. Case report: acute transverse myelitis after zika virus infection. Am J Trop Med Hyg. 2018, 99:1419-21. 10.4269\/ajtmh.17-0938","journal-title":"Am J Trop Med Hyg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12010036","article-title":"Epsilon toxin from Clostridium perfringens causes inhibition of potassium inward rectifier (Kir) channels in oligodendrocytes","volume":"12","author":"Bossu JL","year":"2020","unstructured":"Bossu JL, Wioland L, Doussau F, Isope P, Popoff MR, Poulain B. Epsilon toxin from Clostridium perfringens causes inhibition of potassium inward rectifier (Kir) channels in oligodendrocytes. Toxins (Basel). 2020, 12:10.3390\/toxins12010036","journal-title":"Toxins (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.0489","article-title":"Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"79","author":"Chen JJ","year":"2022","unstructured":"Chen JJ, Huda S, Hacohen Y, et al.. Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease. JAMA Neurol. 2022, 79:518-25. 10.1001\/jamaneurol.2022.0489","journal-title":"JAMA Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/300106-infections-combined-with-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-a-case-report-and-systematic-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T22:59:40Z","timestamp":1728601180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/300106-infections-combined-with-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-a-case-report-and-systematic-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.71229","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,10]]}}}